Lensar (LNSR) Cash from Investing Activities (2019 - 2026)
Lensar (LNSR) posted quarterly Cash from Investing Activities of $4.0 million for Q1 2026, up 653.3% year-over-year from $531000.0 in Q1 2025, and down 5.77% quarter-over-quarter from $4.2 million in Q4 2025.
Lensar (LNSR) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Cash from Investing Activities for 8 consecutive years, with $4.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 653.3% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.8 million (up 1276.49% YoY), while the FY2025 annual figure was $1.3 million, up 159.42% from the prior year.
- Cash from Investing Activities retreated to $4.0 million in Q1 2026 per LNSR's latest filing, from $4.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $4.2 million in Q4 2025 and bottomed at -$7.5 million in Q2 2025.
- Historically, Cash from Investing Activities has averaged -$67529.4 across 5 years, with a median of -$10000.0 in 2022.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities tumbled 45150.0% — and 2026, when it jumped 653.3%.
- Lensar's Cash from Investing Activities stood at -$57000.0 in 2022, then tumbled by 6856.14% to -$4.0 million in 2023, then soared by 150.24% to $2.0 million in 2024, then surged by 113.1% to $4.2 million in 2025, then dropped by 5.77% to $4.0 million in 2026.
- Business Quant data shows LNSR's Cash from Investing Activities at $4.0 million in Q1 2026, $4.2 million in Q4 2025, and $4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Lensar | 101.76 Mn | 88.19 Mn | 9.78 Mn | 965,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 965,000.00 |
| Jun 30, 2026 | 965,000.00 |
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 4.25 Mn |
| Dec 31, 2025 | 4.25 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Mar 31, 2025 | 531,000.00 |
| Mar 31, 2025 | 531,000.00 |
| Dec 31, 2024 | 1.99 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | -905,000.00 |
| Sep 30, 2024 | -905,000.00 |
| Jun 30, 2024 | -2.02 Mn |
| Jun 30, 2024 | -2.02 Mn |
| Mar 31, 2024 | -1.23 Mn |
| Mar 31, 2024 | -1.23 Mn |